The 1,3,4-Thiadiazole Scaffold in Medicinal Chemistry: Structural Insights, Mechanistic Pathways, and Therapeutic Outlook.

Heteroatoms are common structural fragments in many APIs and excipients. Several heterocyclic scaffolds are considered privileged structures. The term Thiadiazole comes from the "Hantzsch-Widman" nomenclature and falls within the category of azole chemicals. These are heterocyclic compounds with 5-membered rings that contain 2 nitrogen atoms and 1 sulfur atom. It exists in 4 isomeric forms, namely 1,2,4-thiadiazole, 1,2,3-thiadiazole, 1,3,4-thiadiazole, and 1,2,5- thiadiazole. The thiadiazole nucleus shows a broad spectrum of biological activities, including antimicrobial, anticonvulsant, anticancer, antiviral, antituberculosis, anti-inflammatory and analgesic, diuretic, antidiabetic, anti-ulcer, antimalarial, and anti-leishmanicidal properties, as well as effects against influenza, hypolipidemia, hyperlipidemia, and hypertension. The most studied of these scaffolds is the 1,3,4-thiadiazole scaffold, and the synthesis of 1,3,4-thiadiazole proceeds through wellestablished reaction pathways, including the intramolecular cyclization of thioacylated intermediates, including acylhydrazide or thiosemicarbazide derivatives, which are either acid- or basecatalyzed and often facilitated by harsh dehydrating agents. The review also addresses the chemical reactivity, substitution behaviour, and stability of the scaffold under various conditions, thereby making it more adaptable for molecular design. Aromatic stability, unique electron distribution, and bioisosteric physicochemical and electronic characteristics of the 1,3,4-thiadiazole core result in improved pharmacodynamic and pharmacokinetic performance, and the use of the 1,3,4-thiadiazole ring is currently and, in the future, a major structural motif in drug discovery. This review summarizes emerging information on the chemistry of 1,3,4-thiadiazole and promotes the exploration of this versatile scaffold for developing new therapeutic agents.